Related Experiment Video
Updated: Feb 21, 2026

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
Published on: February 28, 2012
[Antithrombotic therapy in the elderly - are there differences?]
1Department of Cardiology, Ondokuz Mayıs University Faculty of Medicine, Samsun, Turkey. msahin@omu.edu.tr.
Insights
Elderly populations face increasing risks of atherothrombotic disease. Optimal antithrombotic therapy is crucial but challenging due to increased vulnerability to adverse effects in older adults.
Area of Science:
- Gerontology
- Cardiovascular Medicine
- Pharmacology
Background:
- Atherothrombotic diseases, such as heart attack and stroke, are a significant health concern, particularly in aging populations.
- Antithrombotic therapy is essential for preventing atherothrombosis, but its application in elderly patients presents unique challenges.
- The growing elderly demographic worldwide necessitates a deeper understanding of age-specific treatment strategies.
Purpose of the Study:
- To review and discuss the complexities of antithrombotic therapy selection in elderly patients.
- To highlight the balance between the benefits and risks of antithrombotic agents in older individuals.
- To emphasize the importance of tailored antithrombotic management strategies for the elderly.
Main Methods:
- This review synthesizes current literature on atherothrombosis and antithrombotic treatments in elderly populations.
- Key considerations regarding drug efficacy, safety profiles, and patient-specific factors were analyzed.
- Clinical guidelines and research findings related to antiplatelet and anticoagulant therapies were evaluated.
Main Results:
- While antiplatelet therapy offers proven benefits in preventing atherothrombotic events, elderly patients exhibit a higher susceptibility to bleeding complications.
- Individualized risk-benefit assessments are critical for selecting appropriate antithrombotic agents in this demographic.
- Age-related physiological changes can influence drug pharmacokinetics and pharmacodynamics, impacting treatment outcomes.
Conclusions:
- Effective antithrombotic management in the elderly requires careful consideration of their increased vulnerability to adverse drug events.
- Personalized therapeutic approaches are paramount to optimize the prevention of atherothrombosis while minimizing treatment-related risks.
- Further research is warranted to refine antithrombotic strategies specifically for the aging population.
Abstract:
Atherothrombotic disease increase with age and that the prevalence of the elderly population is continuously growing. Antithrombotic therapy represents the cornerstone of prevention of atherothrombosis. The choice of the antithrombotic therapy in elderly patients remains an ongoing challenge. Althoug the benefits of antiplatelet therapy in the elderly are demonstrated, the elderly are generally more vulnerable to the adverse effects of antithrombotic drugs. Because of them, understanding strategies of antithrombotic management in elderly is important.
Related Concept Videos
Drug Dosing: Geriatric Patients
Pharmacodynamics in Geriatric Patients: Effects of Age
Venous Thrombosis III: Interprofessional Care
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion